- Shares of ClearPoint Neuro ( NASDAQ: CLPT ) on Thursday slumped 9.6% to $8.22 in late afternoon trading.
- The company after hours on Wednesday reported a 21% Y/Y rise in Q4 revenue to $5.2M. FY revenue of $20.55M missed estimates by $0.03M , while FY GAAP EPS of -$0.68 beat expectations by two cents .
- On a negative note, Q4 gross margin fell to 64% from 77% a year ago, primarily due to higher overhead expenses and inventory reserves.
- Analysts were also perhaps disappointed by CLPT reiterating its FY 2023 revenue guidance of $25M to $27M, which came in-line with the consensus estimate of $25.91M.
- The company's cash, cash equivalents and short-term investments at Dec. 31, 2022 was $37.5M, compared to $54.1M at Dec. 31, 2021.
For further details see:
ClearPoint Neuro stock slips more than 9% after reporting Q4 and FY 2022 results